Edaravone suspension for oral administration | Patent Publication Number 20220110915
US 20220110915 A1Patent NumberUS 11478450 B2
Application Number17560493
Filled DateDec 23, 2021
Priority DateNov 1, 2019
Publication DateApr 14, 2022
Original AssigneeMitsubishi Chemical Group Corporation
Current AssigneeMitsubishi Chemical Group Corporation
Inventor/ApplicantsTetsuo Hayama
Tomohiro Takahashi
Tadashi Miyazawa
Tetsuo HAYAMA
Kouji Hayashi
Munetomo Matsuda
Munetomo MATSUDA
Tomoyuki OMURA
Tomoyuki Omura
Tadashi MIYAZAWA
Tomohiro TAKAHASHI
Kouji HAYASHI
Tomohiro Takahashi
Tadashi Miyazawa
Tetsuo HAYAMA
Kouji Hayashi
Munetomo Matsuda
Munetomo MATSUDA
Tomoyuki OMURA
Tomoyuki Omura
Tadashi MIYAZAWA
Tomohiro TAKAHASHI
Kouji HAYASHI
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.